Home
News
Create
Screeners
Insights
Lincoln Pharmaceuticals
634.
60
+105.75
(+20.00%)
Market Cap
₹1,271.09 Cr
PE Ratio
13.30
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+20.00%
1M
+30.36%
6M
+16.22%
1Y
-6.47%
5Y
+184.26%
View Company Insights
Latest news about Lincoln Pharmaceuticals
Lincoln Pharmaceuticals Board Approves Strong Q3FY26 Results with 37.70% Profit Growth
3 hrs ago
Today
Lincoln Pharmaceuticals' Board of Directors approved strong Q3FY26 financial results on February 12, 2026, demonstrating exceptional performance with net profit surging 37.70% to ₹28.60 crore and revenue growing 13.49% to ₹166.32 crore. The company maintains its ambitious target of ₹1,000 crore revenue within three years, supported by robust R&D pipeline and global expansion across 90 countries.
Lincoln Pharmaceuticals Receives CRISIL Credit Rating Reaffirmation at A/Stable for Long-term Facilities
Jan 10, 2026
Lincoln Pharmaceuticals Reports 16.93% Profit Growth in Q1, Reappoints Key Directors
Aug 07, 2025
Lincoln Pharma Reports 17% Net Profit Growth in Q1, Targets ₹1,000 Crore Revenue in 3 Years
Aug 07, 2025
Lincoln Pharmaceuticals Completes Trial Run at Khatraj Facility, Eyes API Production
Jul 02, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation